[go: up one dir, main page]

DE60135364D1 - Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix - Google Patents

Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix

Info

Publication number
DE60135364D1
DE60135364D1 DE60135364T DE60135364T DE60135364D1 DE 60135364 D1 DE60135364 D1 DE 60135364D1 DE 60135364 T DE60135364 T DE 60135364T DE 60135364 T DE60135364 T DE 60135364T DE 60135364 D1 DE60135364 D1 DE 60135364D1
Authority
DE
Germany
Prior art keywords
inhibiting
skin aging
oproteinase
lycopine
carotin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135364T
Other languages
English (en)
Inventor
Lionel Breton
Markus Baur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Application granted granted Critical
Publication of DE60135364D1 publication Critical patent/DE60135364D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
DE60135364T 2000-10-26 2001-10-25 Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix Expired - Lifetime DE60135364D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0013753A FR2815859B1 (fr) 2000-10-26 2000-10-26 Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement
PCT/FR2001/003315 WO2002034232A2 (fr) 2000-10-26 2001-10-25 Utilisation de carotenoides pour traiter les signes cutanes du vieillissement

Publications (1)

Publication Number Publication Date
DE60135364D1 true DE60135364D1 (de) 2008-09-25

Family

ID=8855769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135364T Expired - Lifetime DE60135364D1 (de) 2000-10-26 2001-10-25 Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix

Country Status (9)

Country Link
US (2) US20040071744A1 (de)
EP (1) EP1331924B1 (de)
JP (2) JP2004512294A (de)
AT (1) ATE404163T1 (de)
AU (1) AU2002214102A1 (de)
DE (1) DE60135364D1 (de)
ES (1) ES2312480T3 (de)
FR (1) FR2815859B1 (de)
WO (1) WO2002034232A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829388B1 (fr) * 2001-09-11 2005-09-02 Oreal Utilisation d'au moins un carotenoide dans une composition cosmetique
US20070031356A1 (en) * 2005-07-01 2007-02-08 Petra Buchwald Hunziker Beta-carotene modulation of gene expression
AR059601A1 (es) * 2006-02-21 2008-04-16 Mary Kay Inc Composiciones estables de vitamina c
KR20090003281A (ko) * 2006-03-31 2009-01-09 디에스엠 아이피 어셋츠 비.브이. 신체적 외관의 개선을 위한 화합물 및 화합물의 조합물의 신규한 용도
US8987329B2 (en) 2006-04-12 2015-03-24 Conopco, Inc. Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
US20090286872A1 (en) * 2006-04-12 2009-11-19 John Casey Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
PL2004160T3 (pl) * 2006-04-12 2013-02-28 Unilever Nv Doustna kompozycja o przeciwstarzeniowym działaniu na skórę
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
EP2130833A1 (de) * 2008-06-05 2009-12-09 DSM IP Assets B.V. Verfahren zur Herstellung von Zeacarotinen
EP2676553B1 (de) 2011-02-18 2017-04-12 FUJIFILM Corporation Carotinoidhaltige zusammensetzung
FR2974296B1 (fr) 2011-04-19 2013-05-24 Inneov Lab Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c en tant qu'actif pour l'hydratation de la peau
FR2974300B1 (fr) 2011-04-19 2013-05-10 Inneov Lab Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires
CN114144205A (zh) * 2019-07-24 2022-03-04 赫斯特细胞有限公司 用于伤口愈合的新抗氧化剂组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH552388A (de) * 1970-07-10 1974-08-15 Hoffmann La Roche Lichtschutzmittel.
FR2727018B1 (fr) * 1994-11-17 1997-01-31 Jcb Cosmetiques Composition orale pour la prevention des allergies solaires a base d'un carotenoide, d'un tocopherol, d'acide ascorbique et de selenium
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US6048846A (en) * 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
DE19838636A1 (de) * 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
DE19942774A1 (de) * 1999-09-08 2001-03-15 Cognis Deutschland Gmbh Zubereitungen zur oralen Aufnahme
US20050031557A1 (en) * 1999-09-08 2005-02-10 Christine Gaertner Oral administration of beta-carotene, lycopene and lutein for human skin protection
FR2799370B1 (fr) * 1999-10-07 2005-08-19 Oreal Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement
AU1135701A (en) * 1999-10-14 2001-04-23 Schroeder, Fritz H. Compositions with anti-prostate cancer activity

Also Published As

Publication number Publication date
ATE404163T1 (de) 2008-08-15
ES2312480T3 (es) 2009-03-01
JP2004512294A (ja) 2004-04-22
WO2002034232A3 (fr) 2002-06-27
EP1331924A2 (de) 2003-08-06
JP2008156349A (ja) 2008-07-10
EP1331924B1 (de) 2008-08-13
US20090227688A1 (en) 2009-09-10
FR2815859A1 (fr) 2002-05-03
US20040071744A1 (en) 2004-04-15
FR2815859B1 (fr) 2003-02-28
WO2002034232A2 (fr) 2002-05-02
AU2002214102A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
DE60135364D1 (de) Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
MEP8209A (en) Modified factor viii
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
ATE530179T1 (de) Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen
MXPA02012000A (es) Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE281075T1 (de) Zusammensetzung zum inaktivieren von reizstoffen in flüssigkeiten
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
ATE354565T1 (de) Hydroxyethylamin-derivate für die behandlung von alzheimer
ATE278384T1 (de) Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor
ATE194596T1 (de) N-hydroxypiperidine als superoxid-radikalfänger
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
ATE353667T1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE60118769D1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
WO2002034210A3 (fr) Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition